Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LXO Group, founded in 2015 and headquartered in Saint-Cloud, France, is a dynamic pharmaceutical company specializing in the acquisition and lifecycle management of mature medicines. With a portfolio of 28 brands, including LOXEN®, MANTADIX®, and NIMOTOP®, LXO Group operates in over 80 countries, focusing on therapeutic areas such as cardiology, central nervous system disorders, and internal medicine. The company leverages ...
LXO Group, founded in 2015 and headquartered in Saint-Cloud, France, is a dynamic pharmaceutical company specializing in the acquisition and lifecycle management of mature medicines. With a portfolio of 28 brands, including LOXEN®, MANTADIX®, and NIMOTOP®, LXO Group operates in over 80 countries, focusing on therapeutic areas such as cardiology, central nervous system disorders, and internal medicine. The company leverages its expertise in integrating established medicines to generate organic growth and expand its global footprint

List your booth number for exhibitions, ask us